Skip to main content

26.03.2018 | Original Article | Ausgabe 4/2018

Comparative Clinical Pathology 4/2018

Effects of the hydroalcoholic extract of Artemisia khorassanica on wound healing potential in mice

Comparative Clinical Pathology > Ausgabe 4/2018
Fatemeh Ramezani Nowrozani, Ali Ghorbani Ranjbary


Artemisia is small plant that grows in many parts of Iran and has been reported to have anti-microbial and anti-inflammatory properties. The purpose of this study was to assess the effect of hydroalcoholic extract of Artemisia khorassanica on the wound healing process in rats. Thirty-six adult male Wistar rats were allocated into six equal groups (n = 6). All rats were anaesthetised; a 2-cm square, full thickness skin wound was created on their backs and treatments, depending upon treatment group, were applied twice daily: group A-control—no treatment; group B-placebo—Eucerin (delivery vehicle) only; group C-positive placebo—1% phenytoin cream; groups D, E and F—Artemisia cream treatment at concentrations of 10, 20 and 40% by weight, respectively. The edge of the wound was measured every day and the percentage of wound healing was compared. In this study, the mean time to complete healing in groups control and placebo was 21 days, in group positive placebo 19 days, and in groups 10, 20 and 40% ointment 19, 18 and 16 days, respectively. All treatment groups were statistically significantly different when compared with the control groups (P < 0.05). Extracts of Artemisia khorassanica have been shown to improve outcomes in cutaneous wound healing supporting anti-inflammatory and regenerative properties.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Interdisziplinär

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag als Mediziner

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf

Jetzt e.Med zum Sonderpreis bestellen!

Über diesen Artikel

Weitere Artikel der Ausgabe 4/2018

Comparative Clinical Pathology 4/2018 Zur Ausgabe

Neu im Fachgebiet Pathologie

01.10.2020 | Magenkarzinom | Schwerpunkt: In-situ-Hybridisierung | Ausgabe 6/2020

ISH-basierte HER2-Diagnostik

30.09.2020 | Schwerpunkt: In-situ-Hybridisierung | Ausgabe 6/2020

RNA-in-situ-Hybridisierung: Technologie, Möglichkeiten und Anwendungsbereiche

28.09.2020 | Lungenkarzinome | Schwerpunkt: In-situ-Hybridisierung | Ausgabe 6/2020

Anwendungen der FISH in der Diagnostik von Lungenkarzinomen